|
Boston Scientific (NYSE:BSX), the Natick, MA-based medical devices giant, says that the FDA has approved its stent for certain patients who undergo surgeries to remove plaques from their renal arteries. The stent is designed to prop open renal arteries, which are the main source of blood to the kidneys.
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
